Skip to Content

Aczone Approval History

FDA Approved: Yes (First approved July 7, 2005)
Brand name: Aczone
Generic name: dapsone
Dosage form: Gel
Company: Allergan plc
Treatment for: Acne

Aczone (dapsone) is a sulfone indicated for the topical treatment of acne vulgaris.

Development History and FDA Approval Process for Aczone

DateArticle
Feb 25, 2016Approval Allergan Announces FDA Approval of Aczone (dapsone) Gel, 7.5% for Treatment of Acne Vulgaris
May 29, 2007QLT USA, Inc. files Aczone labeling supplement for removal of blood screening requirement
Sep  1, 2004Atrix and Fujisawa Submit New Drug Application for Acne Product

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide